Immunotherapy – treatment that uses the body’s own immune system to help fight disease – has groundbreaking and life-saving implications. In an effort to make immunotherapy more effective, Wyss Institute researches are developing new immuno-materials, which help modulate immune cells to treat or diagnose disease. In this episode of Disruptive, Dave Mooney, Wyss Core Faculty member; Kai Wucherpfennig, Dana-Farber Cancer Institute Cancer and Immunology and Virology department chair; and Aileen Li, Wyss Institute and Mooney Lab postdoctoral fellow, discuss their collaboration developing an injectable cancer vaccine. Guests also discuss other immuno-material applications, which could treat infections, diabetes, and addiction.

Transcript: https://s3-us-west-2.amazonaws.com/wyss-prod/app/uploads/2020/02/26124017/Ep011_Disruptive_Immuno-Materials.pdf